GeneSystem Co Ltd
KOSDAQ:363250
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vision International Holdings Ltd
HKEX:8107
|
HK |
|
Saab AB
STO:SAAB B
|
SE |
|
China MeiDong Auto Holdings Ltd
HKEX:1268
|
CN |
GeneSystem Co Ltd
Total Current Liabilities
GeneSystem Co Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
GeneSystem Co Ltd
KOSDAQ:363250
|
Total Current Liabilities
₩2.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Total Current Liabilities
₩4.5T
|
CAGR 3-Years
51%
|
CAGR 5-Years
33%
|
CAGR 10-Years
21%
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Total Current Liabilities
₩6.8B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Total Current Liabilities
₩239.7B
|
CAGR 3-Years
36%
|
CAGR 5-Years
62%
|
CAGR 10-Years
89%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Total Current Liabilities
₩123.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
73%
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Total Current Liabilities
₩11.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
GeneSystem Co Ltd
Glance View
Genesystem Co., Ltd engages in providing PCR based molecular diagnostic products. The firm is engaged in the development, manufacture and sale of platform based on molecular diagnosis. The firm develops and manufactures products such as molecular diagnosis systems, biochips, test kits, and reaction reagents, among others. The firm develops in vitro diagnostic technology through immunodiagnosis technology and molecular diagnosis technology.
See Also
What is GeneSystem Co Ltd's Total Current Liabilities?
Total Current Liabilities
2.5B
KRW
Based on the financial report for Dec 31, 2024, GeneSystem Co Ltd's Total Current Liabilities amounts to 2.5B KRW.
What is GeneSystem Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
-25%
Over the last year, the Total Current Liabilities growth was 4%. The average annual Total Current Liabilities growth rates for GeneSystem Co Ltd have been -1% over the past three years , -25% over the past five years .
